DEA Form 363: Registering a Narcotic Treatment Program

An opioid treatment program (OTP) dispenses Schedule II narcotics every day, so DEA treats it as its own kind of registrant: a narcotic treatment program (NTP). A physician's practitioner registration does not cover it, and neither does a hospital or clinic registration. The program applies on DEA Form 363, and it "must be registered by the DEA before administering or dispensing" medication for opioid use disorder (42 CFR 8.11(e)(6)).

Which activities does an NTP registration cover?

DEA's registration table lists "Narcotic Treatment Program (including compounder)" as its own business activity: narcotic drugs in Schedules II through V, new applications on Form 363, renewals on Form 363a, an application fee of $296, and a registration period of one year (21 CFR 1301.13(e)(1)(viii)). The coincident activity it allows is operating "one or more mobile narcotic treatment programs," with DEA approval.

DEA's Narcotic Treatment Program Manual (revised 2022) adds the practical points:

• DEA uses six business activities to describe what an NTP may do: maintenance, detoxification, or both, each with or without compounding.
• "If a person owns and operates more than one NTP, each place of business must be separately registered with DEA," consistent with 21 CFR 1301.12(a).
• An NTP that will dispense FDA-approved Schedule III narcotics for opioid use disorder, such as buprenorphine, must ask DEA to modify its registration to add Schedule III.
• The registration needs a business address, which becomes the "controlled premises" where records, stock and the certificate are kept, and a mailing address, which can differ.

How do you file Form 363?

Online only. DEA's rules say "only applications submitted online through the secure application portal on DEA's website will be accepted for processing" (21 CFR 1301.13(e)(2)), and all applications are "submitted for filing online using the secure application portal" (1301.14(a)). The system dates the application on receipt and rejects incomplete ones with error messages at the time of filing. Acceptance for filing "has no bearing on whether the application will be granted" (1301.14(c)).

The application must "include all information called for in the form, unless the item is not applicable, in which case this fact shall be indicated" (1301.13(i)). Practically, that means having the program's legal name, tax identification, registered and mailing addresses, the business activity and schedules, and the state license or authority details ready before you start.

Who signs the application?

DEA's signature rule is 21 CFR 1301.13(j). Each application and attachment "shall be signed by the applicant, if an individual; by a partner of the applicant, if a partnership; or by an officer of the applicant, if a corporation, corporate division, association, trust or other entity." The rule also allows an applicant to authorize other individuals to sign by filing a power of attorney with DEA's Registration Unit.

That option exists, but we do not use it. We prepare the information for Form 363 and the program's officer signs and pays DEA. We never accept a DEA power of attorney and never sign a DEA form. A controlled substance registration is too consequential for anyone outside the program to sign.

Does DEA inspect before it registers the program?

DEA's NTP Manual describes the approval process: "Once DEA receives a new application, the local DEA Diversion Field Office contacts the NTP to schedule an on-site, pre-registration investigation." DEA staff explain recordkeeping and security requirements, test and evaluate the security systems, and verify "state licensure with SOTA and certification by SAMHSA." On approval DEA issues a Certificate of Registration (DEA Form 223), which must be kept at the registered location.

That verification step is why the four approvals interlock. SAMHSA will not grant provisional certification without state and DEA approvals, and DEA checks for state licensure and SAMHSA certification. In practice the agencies coordinate: SAMHSA's compliance officer collects the state and DEA approvals, and once SAMHSA determines the program qualifies it notifies DEA within five days (42 CFR 8.11(c)(3)). Until the registration is granted, the program may not order, store or dispense controlled substances (21 CFR 1301.13(a)).

Which security rules shape the floor plan?

NTPs fall under DEA's physical security rules for non-practitioners in 21 CFR 1301.72 and the other security controls in 1301.74. A few NTP-specific rules shape the floor plan and the staffing plan:

• Deliveries. Narcotics may be accepted only by a licensed practitioner employed at the facility or another individual designated in writing, who signs the invoice (1301.74(h)).
• Who dispenses. Narcotics are dispensed or administered directly to the patient by the licensed practitioner, or by a registered nurse, licensed practical nurse or pharmacist under the practitioner's direction (1301.74(i)).
• Separate waiting area. Patients wait "in an area that is physically separated from the narcotic storage and dispensing area by a physical entrance such as a door or other entryway" (1301.74(j)).
• Take-home limits. NTPs must follow the HHS standards on unsupervised doses (1301.74(k)), which are SAMHSA's take-home rules in 42 CFR 8.12(i).
• DEA discretion. DEA may set the degree of security based on the program's location, patient numbers, and numbers of practitioners, staff and guards (1301.74(l)).

Build these into the facility diagram from the start. The same diagram goes to SAMHSA with the SMA-162, and SAMHSA wants the dispensing and counseling space described too.

Can the registration cover mobile units?

An NTP may operate a mobile component under its existing registration, but only after it notifies the local DEA office in writing and receives "explicit written approval from the local DEA office prior to operating the mobile NTP," and "the mobile NTP may only operate in the same State in which the NTP is registered" (21 CFR 1301.13(e)(4)). The conveyance needs its own safe, alarm and handling procedures (1301.72(e)). Our post on adding a medication unit covers SAMHSA's side.

Do later changes need DEA approval?

According to DEA's NTP Manual, a registration modification is needed for a change of business or mailing address, a name change, a change of schedules, or becoming an authorized collector, and there is no fee for a modification. For a move, DEA recommends requesting the change at least 60 days ahead and "will not approve the change of address of the NTP without the proper authorizations from the SOTA and SAMHSA." The program cannot handle controlled substances at the new site until DEA approves. Renewals are covered in renewing a DEA NTP registration.

How do we fit in?

Form 363 preparation is part of our Opioid Treatment Program Approval Package ($6,995 plus the state license package): we assemble the registration information, align the facility diagram with DEA's security and waiting-area rules, and prepare the team for the pre-registration visit. Your officer signs and submits the application and pays DEA's fee directly. Annual renewal support is our DEA NTP Registration Renewal service ($249). See pricing and the OTP approval hub.